Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heng Hu

Showing results (261-270 of 269) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 269 results.
Hepatology (Baltimore, Md.)|July 18, 2015
RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinomaHuey-Huey Chua, Daw-Jen Tsuei, Po-Huang Lee, et al.
BMC Musculoskeletal Disorders|July 5, 2018
Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D<sub>3</sub> combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisalEr-Yuan Liao, Zhen-Lin Zhang, Wei-Bo Xia, et al.
Medicine|August 5, 2018
Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in ChinaEr-Yuan Liao, Zhen-Lin Zhang, Wei-Bo Xia, et al.
Liver Cancer|February 12, 2024
HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct FeaturesChiao-Ling Li, Chia-Lang Hsu, You-Yu Lin, et al.
Cell Metabolism|June 19, 2021
Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1Lin Wang, Xin Zhang, Zhi-Bin Lin, et al.
Orphanet Journal of Rare Diseases|April 4, 2019
Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groupsTzu-Hung Chu, Yin-Hsiu Chien, Hsiang-Yu Lin, et al.
Journal of Alzheimer'S Disease : JAD|August 30, 2021
Urban-Rural Disparities in the Association Between Body Mass Index and Cognitive Impairment in Older Adults: A Cross-Sectional Study in Central ChinaJing-Jing Zhang, Lin Li, Dan Liu, et al.
Journal of Hepatology|March 24, 2009
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosageChun-Jen Liu, Po-Huang Lee, Deng-Yn Lin, et al.
World Journal of Gastroenterology|August 30, 2014
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrenceChun-Jen Liu, Juliana Chang, Po-Huang Lee, et al.
Pageof 27

Showing results (261-270 of 269) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 269 results.
Hepatology (Baltimore, Md.)|July 18, 2015
RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinomaHuey-Huey Chua, Daw-Jen Tsuei, Po-Huang Lee, et al.
BMC Musculoskeletal Disorders|July 5, 2018
Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D<sub>3</sub> combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisalEr-Yuan Liao, Zhen-Lin Zhang, Wei-Bo Xia, et al.
Medicine|August 5, 2018
Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in ChinaEr-Yuan Liao, Zhen-Lin Zhang, Wei-Bo Xia, et al.
Liver Cancer|February 12, 2024
HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct FeaturesChiao-Ling Li, Chia-Lang Hsu, You-Yu Lin, et al.
Cell Metabolism|June 19, 2021
Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1Lin Wang, Xin Zhang, Zhi-Bin Lin, et al.
Orphanet Journal of Rare Diseases|April 4, 2019
Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groupsTzu-Hung Chu, Yin-Hsiu Chien, Hsiang-Yu Lin, et al.
Journal of Alzheimer'S Disease : JAD|August 30, 2021
Urban-Rural Disparities in the Association Between Body Mass Index and Cognitive Impairment in Older Adults: A Cross-Sectional Study in Central ChinaJing-Jing Zhang, Lin Li, Dan Liu, et al.
Journal of Hepatology|March 24, 2009
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosageChun-Jen Liu, Po-Huang Lee, Deng-Yn Lin, et al.
World Journal of Gastroenterology|August 30, 2014
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrenceChun-Jen Liu, Juliana Chang, Po-Huang Lee, et al.
Pageof 27